ES2091970T3 - Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales. - Google Patents

Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.

Info

Publication number
ES2091970T3
ES2091970T3 ES92105717T ES92105717T ES2091970T3 ES 2091970 T3 ES2091970 T3 ES 2091970T3 ES 92105717 T ES92105717 T ES 92105717T ES 92105717 T ES92105717 T ES 92105717T ES 2091970 T3 ES2091970 T3 ES 2091970T3
Authority
ES
Spain
Prior art keywords
gastrorresistent
gastro
oral administration
controlled release
biliar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92105717T
Other languages
English (en)
Spanish (es)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Application granted granted Critical
Publication of ES2091970T3 publication Critical patent/ES2091970T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES92105717T 1991-04-12 1992-04-02 Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales. Expired - Lifetime ES2091970T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Publications (1)

Publication Number Publication Date
ES2091970T3 true ES2091970T3 (es) 1996-11-16

Family

ID=11337392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92105717T Expired - Lifetime ES2091970T3 (es) 1991-04-12 1992-04-02 Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.

Country Status (9)

Country Link
US (1) US5300300A (OSRAM)
EP (1) EP0508312B1 (OSRAM)
JP (1) JP2509046B2 (OSRAM)
KR (1) KR970005177B1 (OSRAM)
CA (1) CA2065652C (OSRAM)
DE (1) DE69213800T2 (OSRAM)
ES (1) ES2091970T3 (OSRAM)
IT (1) IT1245891B (OSRAM)
TW (1) TW215899B (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
PT1113785E (pt) 1998-07-24 2005-08-31 Seo Hong Yoo Solucoes aquosas limpidas de acidos biliares
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
KR100848344B1 (ko) * 2000-02-04 2008-07-25 유서홍 담즙산 함유 청정 수용액 제형의 제조
US6821931B2 (en) * 2002-03-05 2004-11-23 Alpine Mud Products Corporation Water-based drilling fluid additive containing talc and carrier
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
US20070015796A1 (en) * 2003-09-26 2007-01-18 Smithkline Beecham Corporation Compositions and methods for treatment of fibrosis
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US8173627B2 (en) * 2004-08-30 2012-05-08 Seo Hong Yoo Neuroprotective effect of solubilized UDCA in focal ischemic model
WO2006044771A2 (en) * 2004-10-15 2006-04-27 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
CA2673665C (en) * 2006-12-22 2017-03-21 Ironwood Pharmaceuticals, Inc. Method and compositions for treating esophageal disorders
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
AU2012322323B2 (en) 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
BR112022001645A2 (pt) 2019-08-12 2022-05-03 Massachusetts Inst Technology Artigo configurado para liberação de um agente terapêutico, e, métodos para distribuir fármaco intestinal e para administrar um agente terapêutico
CN118217294B (zh) * 2023-08-08 2024-11-29 成都赛璟生物医药科技有限公司 一种熊去氧胆酸复合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
IT1101649B (it) 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1212141B (it) 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.

Also Published As

Publication number Publication date
CA2065652C (en) 1999-01-12
DE69213800T2 (de) 1997-02-20
JP2509046B2 (ja) 1996-06-19
EP0508312B1 (en) 1996-09-18
KR970005177B1 (ko) 1997-04-14
JPH0597677A (ja) 1993-04-20
ITBO910114A0 (it) 1991-04-12
KR920019360A (ko) 1992-11-19
DE69213800D1 (de) 1996-10-24
TW215899B (OSRAM) 1993-11-11
ITBO910114A1 (it) 1992-10-12
IT1245891B (it) 1994-10-25
US5300300A (en) 1994-04-05
EP0508312A1 (en) 1992-10-14
CA2065652A1 (en) 1992-10-13

Similar Documents

Publication Publication Date Title
ES2091970T3 (es) Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
ES2090394T3 (es) Formulados farmaceuticos gastroresistentes para administracion oral conteniendo sales de acidos biliares.
ES2090395T3 (es) Formulados farmaceuticos gastroresistentes para administracion por via oral que contienen acidos biliares.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
ES2114562T3 (es) Forma de dosificacion para distribucion retardada de farmacos.
ATE19589T1 (de) Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung.
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ES2117146T3 (es) Tableta farmaceutica capaz de liberar una o varias sustancias medicamentosas a diferentes velocidades.
GR1000465B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
ES2185816T3 (es) Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico.
SV1997000008A (es) Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion.
CY1106072T1 (el) Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
FI954767A7 (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
NO890194L (no) Galenisk middel.
CO5251435A1 (es) Composicion orales estables de liberacion extendida que comprenden un nucleo de pseudoefedrina, una capa de separacion y una capa de desloratadina
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
AR033688A1 (es) Composicion parenteral reconstituible
MX9100080A (es) Composiciones farmaceuticas y metodos para aliviar sintomas gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
PA8523101A1 (es) Composicion de eletriptan en forma de particulas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 508312

Country of ref document: ES